Trial intelligence / Profile preview

Generic versus original hyperbaric bupivacaine in spinal anaesthesia

PACTR201807735986564Not yet recruiting

Sponsor
Pireshin Ramdharee Professional Corporation
Start
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine in None (2 arms), sponsored by Pireshin Ramdharee Professional Corporation. Primary endpoint: Sensory level achieved. Planned start Jul 2018; status: not yet recruiting.

02

Drugs

bupivacaine

Beyond the preview

Go deeper on PACTR201807735986564.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201807735986564.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call